Tentative Approval of Clobetasol Propionate Emulsion Foam

Perrigo Company announced that it received tentative approval of its Abbreviated New Drug Application (ANDA) for clobetasol propionate emulsion foam, 0.05%. The product is the AB-rated equivalent to Stiefel Laboratories' Olux -E Foam, 0.05%, a topical corticosteroid indicated for the treatment of moderate to severe dermatosis of the scalp.

For more information call (866) 634-9120 or visit www.perrigo.com.